Pediatrix Medical Group Inc/ US58502B1061 /
2024-06-07 10:10:00 PM | Chg. +0.23 | Volume | Bid10:05:03 AM | Ask10:05:03 AM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
7.12USD | +3.34% | 2.67 mill. Turnover: 17.11 mill. |
6.70Bid Size: 500 | 11.32Ask Size: 100 | 599.13 mill.USD | - | 9.75 |
Assets
2013 US GAAP in mill. USD |
2014 US GAAP in mill. USD |
2015 US GAAP in mill. USD |
2016 US GAAP in mill. USD |
2017 US GAAP in mill. USD |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Property and Equipment | 59.9000 | 66.0480 | 83.6340 | 103.0680 | 123.5360 | ||||||
Intangible Assets | 0.0000 | - | 424.2190 | 668.5290 | 639.9280 | ||||||
Long-Term Investments | - | - | - | - | - | ||||||
Fixed Assets | - | 3,141.7430 | 4,019.4450 | 4,752.2720 | 5,240.0430 | ||||||
Inventories | - | - | - | - | - | ||||||
Accounts Receivable | 285.4000 | 352.1910 | 444.7370 | 495.2760 | 503.9990 | ||||||
Cash and Cash Equivalents | 31.1000 | 47.9280 | 51.5720 | 55.6980 | 60.2000 | ||||||
Current Assets | 408.8000 | 467.0520 | 527.7690 | 587.1280 | 627.2350 | ||||||
Total Assets | 3,049.4000 | 3,608.7950 | 4,547.2140 | 5,339.4000 | 5,867.2780 |
Liabilities
2013 US GAAP in mill. USD |
2014 US GAAP in mill. USD |
2015 US GAAP in mill. USD |
2016 US GAAP in mill. USD |
2017 US GAAP in mill. USD |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Accounts Payable | 18.6000 | - | - | - | - | ||||||
Long-term debt | 27 | 368 | 1,262.8200 | 1,683.6280 | 1,851.4230 | ||||||
Liabilities to Banks | 27 | 368 | 343.5000 | 783.5000 | 1,110.5000 | ||||||
Provisions | 170.1000 | 185.7000 | 210.1000 | 246.8000 | 239.8000 | ||||||
Liabilities | 706.4000 | 1,343.2290 | 2,109.3680 | 2,578.6330 | 2,800.8240 | ||||||
Share Capital | 1 | .9600 | .9370 | .9370 | .9370 | ||||||
Total Equity | 2,343 | 2,265.5660 | 2,437.8460 | 2,760.7670 | 3,066.4540 | ||||||
Minority Interests | 0.0000 | .9470 | .3180 | 0.0000 | 0.0000 | ||||||
Total liabilities equity | 3,049.4000 | 3,608.7950 | 4,547.2140 | 5,339.4000 | 5,867.2780 |
Income Statement
2013 US GAAP in mill. USD |
2014 US GAAP in mill. USD |
2015 US GAAP in mill. USD |
2016 US GAAP in mill. USD |
2017 US GAAP in mill. USD |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Revenues | 2,154 | 2,438.9130 | 2,779.9960 | 3,183.1590 | 3,458.3120 | ||||||
Depreciation (total) | 40 | 45.9900 | 64.2280 | 89.2640 | 102.8790 | ||||||
Operating Result | 452.1000 | 512.9990 | 557.8680 | 571.6870 | 480.0760 | ||||||
Interest Income | -5.4000 | -8.8910 | -23.1100 | -63.0920 | -74.5590 | ||||||
Income Before Taxes | 448.4000 | 508.6160 | 539.7290 | 513.7990 | 410.4220 | ||||||
Income Taxes | 167.9000 | 191.4130 | 204.0380 | 189.2030 | -90.0500 | ||||||
Minority Interests Profit | 0.0000 | .0780 | .6290 | .3180 | 0.0000 | ||||||
Net Income | 280.5000 | 317.2810 | 336.3200 | 324.9140 | 320.3720 |
Per Share
Cash Flow
2013 US GAAP in mill. USD |
2014 US GAAP in mill. USD |
2015 US GAAP in mill. USD |
2016 US GAAP in mill. USD |
2017 US GAAP in mill. USD |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Cash Flow from Operating Activities | 405.4000 | 422.6410 | 368.7010 | 443.7780 | 511.3780 | ||||||
Cash Flow from Investing Activities | -263.5000 | -503.6040 | -848 | -821.2170 | -576.6130 | ||||||
Cash Flow from Financing | -132.1000 | 97.7540 | 482.9430 | 381.5650 | 89.7370 | ||||||
Decrease / Increase in Cash | 9.9000 | 16.7910 | 3.6440 | 4.1260 | 24.5020 | ||||||
Employees | 8,800 | 10,175 | 11,885 | 14,615 | 15,900 |